gdp's Comments

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : What If Our Generics Strategy Has Been All Wrong

Wed, 7 Aug 2019 19:12:12 +0000

Thank you, Joel. A "quantum shift" is a great way to phrase what's needed. FYI Part 2 of this is now live on our homepage, and final part 3 will be out subsequently ... Louis

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : How Will New Trade Agreements Impact The Pharma Industry … And Patient Access To Medicines

Mon, 3 Dec 2018 13:46:39 +0000

I'm curious, Dr. Shah, if you are actually anathema to any attempts to reign in IP theft, and unbalanced costs of drugs between the U.S. and the rest of the world. Obviously, with phrasing such as "trade regime unleashed by President Trump," " under pressure from the U.S., it is stripped of language," and the closer: "An industry that saves lives of people will unwittingly provide further fodder to those who wish to tarnish its image," you don't like the current U.S. position or president. Are you thus saying the U.S. should just let the status quo continue ... and that would be good for U.S. patients (and companies)? Again ... just curious about your further thinking here. Thank you. Louis Garguilo Chief Editor

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : 2 Reasons Your CDMOs Are Consolidating Money Muscle

Wed, 28 Nov 2018 14:45:55 +0000

Thanks for reading, Ken, and the thoughtful "angle" on all us. A lot to consider on all sides of the M&A/consolidation discussion.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : Biologics In China Market-Driven Inevitability New Quality Start

Tue, 27 Nov 2018 22:47:02 +0000

As always, thank you, Rosemary, for your well-researched analysis on what is happening -- or may well happen -- between the U.S. and China.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : 10 CDMOs 2 Cancer Therapies And An Eye On Analytical Services

Wed, 24 Oct 2018 18:38:52 +0000

Thank you for being a part of Outsourced Pharma San Diego, David. And congratulations again on the formation of Ajinomoto Bio-Pharma Services.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : Levels Of Risk Severity In Biopharma’s Global Outsourcing

Wed, 3 Oct 2018 15:59:28 +0000

Thank you for your insight and sharing your experiences, Dr. Chocarro. Yes, time to place, if you will, the "quality credibility" and full reliability of global outsourcing squarely on the discussion table. Also, I'm very interested in the social anthropology and organizational culture research ... I will follow up with on that. Thank you again.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : President Trump Communist China and Pharma Outsourcing

Fri, 24 Aug 2018 14:34:26 +0000

Pavan, Apologies for any "incoherence," and completely agreed: This subject requires more attention. That I will give it -- hopefully with increasing clarity. For now, more than making points, what is most important is the bio/pharma industry publicly answering this question: Why do you outsource so much of our drug supply chain to China, where quality, IP, and national concerns abound?

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : President Trump Communist China and Pharma Outsourcing

Wed, 22 Aug 2018 17:39:37 +0000

Tom, Thank you for your expert economic analysis, and further background/commentary/sources regarding this complicated societal and international market/business challenge. A lot to unpack, but I'll reply here to one of your direct questions, which I think is really the main kernel of the article: Viewing from the "freedom" lens, I'd say Americans have fought for fair and equitable trade since ... the revolutionary war.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : President Trump Communist China and Pharma Outsourcing

Wed, 22 Aug 2018 16:38:53 +0000

Great questions and comments, Alex. I particularly stayed away from focusing on price in this editorial ... but it has to be a main part of the global dialogue. And that, as you point out, includes consumers/patients here in the U.S., who are always demanding cheaper costing drugs. We've got a systemic challenge within a broken system ... not a good recipe currently.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : “SOPs In Action” For Effective QA Audits Of CDMOs

Mon, 20 Aug 2018 19:24:42 +0000

Thank you,Pavan. I have done articles with Indian executives in the past,and on India in general, as it relates to the CDMO/CMO network there. But you are right: I have not interviewed Indian Pharma (drug sponsors). Any suggestions or introductions you'd like to make? Feel free to email me at: Louis.Garguilo@LifeScienceConnect.com .

Life Science Leader : The Drug Pricing Dilemma Pfizer And President Trump

Mon, 16 Jul 2018 11:26:53 +0000

Kudos for writing this blog, Rob. It is the Chinese who long ago “embarked on a trade war” with the U.S. Trump just decided to fight back, whereas past U.S. administrations were satisfied to cede ground year after year. You mention a “shuddering” U.S. stock market. The shudders have been easily shaken off. As of this writing, the three major indices (Dow, S&P 500; NASDAQ) are at or near historic highs. On the other hand, the Chinese markets (and as you mention, currency), are not fairing as well. But here is what is most important to us specifically, and remarkably still unexplored publically: A major nexus between Trump’s “America First” agenda and the pharma industry is in fact China. Over at LSL sister publication Outsourced Pharma, I wrote a while back in an editorial (Biopharma Outsourcing Shall Be Revealed) that the general public one day will come to understand the full extent of the drug development and manufacturing our pharma industry outsources to China. Drug supply chains for U.S. patients are in many cases dependent on China, a dangerous situation. China thus also plays a role in the pricing of drugs in the U.S., and the profitability of U.S. pharma companies. Trump, pharma and China are more closely intertwined than many understand. But again, that public enlightenment can’t be far away. Trump may ensure that revelation happens on his watch. As you say, “yadda yadda” won’t be a good explanation to U.S. consumers and patients of the predicament. Louis Garguilo Chief Editor / Conference Chair Outsourced Pharma

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : The SEC And The Risk of Biopharma Outsourcing

Wed, 4 Jul 2018 16:44:09 +0000

Thank you for the comments and further insight, David. I have to give some credit here to Outsourced Pharma Boston 2018 panelist (and sponsor) Bob DiScipio, for really pushing to make sure this aspect of our ubiquitous outsourcing becomes top of mind for our readers and conference attendees.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : Former Kodak Park Future Super Site For Biopharma

Fri, 1 Jun 2018 13:07:27 +0000

Thanks for adding a bit more background to the Rochester experience, Jason. Much appreciated.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : Former Kodak Park Future Super Site For Biopharma

Fri, 1 Jun 2018 13:06:14 +0000

Thank you for the further insight, Jeff. I, too, quickly came to understand the vital role (or lack of) for Angel investors, VC or other private equity, in a region looking to grow biopharma. I'll look into taking you up on an investigation of "the aggregation of capital sources" in biotech hubs ... Thanks again.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : Former Kodak Park Future Super Site For Biopharma

Thu, 31 May 2018 13:55:46 +0000

Thanks, Rob. Utica, Syracuse, Rochester, Buffalo and on to Erie. Each city and area has its separate challenges, but the success of each can also help with the economic success of the others. And that chain of success can be applied throughout the U.S. to areas looking to move forward. Bio/Pharma/CDMO companies continue to increase as drivers for development.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : We Weren’t Prepared For CAR-T Lessons From An Industry Executive

Wed, 23 May 2018 17:46:12 +0000

Thanks Bikash and Steve. I'll make sure Joanne sees these nice comments. As always, I appreciate your readership and participation in Outsourced Pharma. (And it was great to see you at OP-Boston, Bikash.)

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : Japan Pharma Top Tier With Tons Of Opportunity

Thu, 22 Feb 2018 20:39:37 +0000

Thank you for reading and your comment, Jeremy. Much appreciated.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : Japan Pharma Top Tier With Tons Of Opportunity

Wed, 21 Feb 2018 16:04:47 +0000

I've received quite a few inquiries as to what city is in our photo accompanying this article. It is in fact Osaka, my past home of many years.

Life Science Leader : Can Boston And San Francisco Remain The Center Of Biopharma’s Universe

Fri, 16 Feb 2018 14:37:08 +0000

Rob: Indeed, Outsourced Pharma Philadelphia looks to be both another exciting OP conference, such as we have had annually in Boston,San Diego and San Francisco, but also a unique venue for us to talk about drug development and manufacturing outsourcing. The agenda for OP-Philly has been released ( http://outsourcedpharmaevents.com/agenda/agenda-p... ). The U.S. certainly has room for even more biopharma clusters to expand to can't-overlook status, even while the established centers work through their growth and success.

OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services : Our 2018 Outsourcing Outlook Focus On … Amazon

Wed, 3 Jan 2018 17:06:00 +0000

Thank you, Steve. And Happy New Year!